Community actions
-
Holding
-
Recently bought
-
Recently sold
Sangamo Therapeutics, Inc. news
-
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
-
Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into Financials and Strategic Highlights
-
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
-
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
-
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
-
Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
-
What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today
-
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
Recent Motivations